Prenalterol [prenalterol]
topical
- Terms
-
prenalterol-hydrochlorid
-
A-Ba-C-50,005
H-133-22
H-80-62
KWD-2033
Prenalterol Hydrochloride
Persistent link
https://www.medvik.cz/link/D011294
Definition
A partial adrenergic agonist with functional beta 1-receptor specificity and inotropic effect. It is effective in the treatment of acute CARDIAC FAILURE, postmyocardial infarction low-output syndrome, SHOCK, and reducing ORTHOSTATIC HYPOTENSION in the SHY-RAGER SYNDROME.
- DUI
- D011294 MeSH Browser
- CUI
- M0017537
- CAS
- Phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, (S)-
- Previous indexing
- Practolol/analogs and derivatives (1975-1986); Propylamines (1966-1974)
- History note
- 87
- Public note
- 87
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UR
- urine 0
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.033.100.624.698
Phenoxypropanolamines
D02.033.100.624.698.115
Bunolol
D02.033.100.624.698.146
Bupranolol
D02.033.100.624.698.688
Penbutolol
D02.033.100.624.698.708
Prenalterol
D02.033.100.624.698.855
Xamoterol
D02.033.755.624.698
Phenoxypropanolamines
D02.033.755.624.698.115
Bunolol
D02.033.755.624.698.146
Bupranolol
D02.033.755.624.698.688
Penbutolol
D02.033.755.624.698.708
Prenalterol
D02.033.755.624.698.855
Xamoterol
D02.092.063.624.698
Phenoxypropanolamines
D02.092.063.624.698.115
Bunolol
D02.092.063.624.698.146
Bupranolol
D02.092.063.624.698.688
Penbutolol
D02.092.063.624.698.708
Prenalterol
D02.092.063.624.698.855
Xamoterol